Succeeding with world-class medicine

M1 Kliniken AG

Medical Care For a Better Life – with this vision M1 Kliniken AG, one of the fastest growing healthcare services providers in Germany, has developed an innovative concept, which offers affordable access to beauty treatments at highest qualitative standards.

M1 stock

ISIN: DE000A0STSQ8 | WKN: A0STSQ | Ticker symbol: M12

Title name: Bearer Share
Number of shares: 19.643.403
Stock exchange: Frankfurt, Stuttgart, Berlin, Düsseldorf, München, Hannover, Xetra, Hamburg, Tradegate Exchange
Market segment: Open Market
Designated Sponsoring: mwb fairtrade
Inital trading day: 14.09.2015

More information

| Investor News

  • Management is open to interested parties
  • Valuations in the peer group of up to 30 times the annual EBITDA
  • M1 Kliniken AG expects EBITDA of over EUR 27 million in 2024

| Investor News

By acquiring the German Nutri Care GmbH and its wholly-owned subsidiary, the Dutch online pharmacy "Direct Apotheke Venlo B.V.," M1 Kliniken AG (ISIN: DE000A0STSQ8) taps into a significant growth field and expands the value chain of its health services. Direct Apotheke Venlo B.V., based in Maasbree (NL), is one of the rapidly growing providers in the online pharmacy business for aesthetic pharmaceuticals, with current core markets in Germany and the Netherlands. In the fiscal year 2022, the company recorded double-digit million-euro revenues and continues on a growth trajectory.

| Investor News

  • Group sales increase by over 10% to EUR 236.6 million in the first nine months of the 2023 financial year (previous year: EUR 214.2 million).

  • Group EBITDA increases by over 55% from EUR 10.9 million to EUR 16.9 million.

  • The operating result (Group EBIT) increases by over 98% to EUR 12.9 million (previous year: EUR 6.5 million).

  • Beauty segment: sales increase of 28.5% to EUR 53.2 million (previous year: EUR 41.4 million) and sharp rise in the Beauty EBIT margin from 8.2% to 23.5%

Contact

M1 Kliniken AG

Grünauer Straße 5
12557 Berlin
Germany

T. +49 (0) 30 347 47 44 14

Contact us